Management of advanced prostate cancer, particularly in cases of metastatic castration-resistant prostate cancer (mCRPC), typically involves first-line treatment with the chemotherapeutic agent docetaxel. Nevertheless, disease progression following docetaxel therapy remains a major challenge, as there are currently no therapeutic options listed in

Together with the Mahidol Oxford Tropical Medicine Research Unit (MORU), HITAP has been engaged in assisting with building technical capacity for HTA and more broadly, evidence-informed decisions for health care in Laos since 2019. Towards this objective, HITAP hosted researchers from University of Health Sciences (UHS) and Lao-Oxford-Mahosot Hospi

With Universal Health Coverage (UHC) high on the global health agenda, governments of many low- and middle-income countries (LMICs) have pledged to increase health investments in the scale-up of essential health services to meet the needs of their people. This has led to the recognition of hea

In the Philippines, use of HTA is not completely new; there have been prior efforts to institutionalize a fair and systematic process of generating policy-relevant evidence to inform coverage of health services, such as listing of drugs in the national formulary and new benefits in the national soci

Abstract India’s rapid economic growth has been accompanied by slower improvements in population health. Given the need to reconcile the ambitious goal of achieving Universal Coverage with limited resources, a robust priority-setting mechanism is required to ensure that the right trade-offs arema

Global health is defined as health issues that transcend national boundaries. This notion implies a shared global responsibility for health and is associated with actors beyond country government. In WHO South-East Asia Region (SEAR), the Regional Committee adopted a resolution in 2010 to enco

RIVERSIDE, Calif. — In the Inland Empire, an economically depressed region in Southern California, President Obama’s health care law is expected to extend insurance coverage to more than 300,000 people by 2014. But coverage will not necessarily translate into care: Local health experts doubt there w

Acknowledgements This report was prepared by Dr. Zin Nwe Win, Dr. Shiela Marie Selisana, and Ms. Thitipanchaya Panya from the Health Intervention and Technology Assessment Program Foundation (HITAP) and reviewed by Ms. Saudamini Vishwanath Dabak. The meeting was conducted in collaboration with

Kidney failure is the most advanced stage of chronic kidney disease, at which point patients require kidney replacement therapy (KRT) in the form of kidney transplant or lifelong dialysis to survive. Although many governments seek to provide KRT for patients with kidney failure under publicly funded

The Health Intervention and Technology Assessment Program (HITAP), Ministry of Public Health, Thailand, has been working with the Health Technology Assessment Committee (HTAC), Ministry of Health, Indonesia, since 2014 under the auspices of the International Decision Support Initiative (iDSI). Si